Tag Archives: kinetic biomarkers

January, 2016

  • 4 January

    Pfizer Partners with KineMed for Development of Kinetic Biomarkers

    SAN FRANCISCO–(BUSINESS WIRE)–KineMed Inc. today announced that it has entered into a strategic collaboration with Pfizer Inc. (NYSE:PFE) to discover and develop novel proprietary biomarkers in various fields of unmet medical need. KineMed’s platform technology provides a proprietary, rate-based approach for developing novel biomarkers. By utilizing mass spectroscopy and stable …